November 18, 2026
Health news, explained with evidence
LIVE

Study Suggests Tissue and Liquid Biopsies Offer Complementary Insights in Advanced Prostate Cancer

🧠 AI Analysis 2 min read 👁 3

Recent research presented at the ESMO congress indicates that combining tissue and liquid biopsies may improve mutation detection in metastatic castration-resistant prostate cancer.

Study Suggests Tissue and Liquid Biopsies Offer Complementary Insights in Advanced Prostate Cancer🧠AI Analysis

Photo: medpagetoday.com

Key points

  • Tissue and liquid biopsies may offer complementary data in prostate cancer.
  • No statistically significant ethnic differences were found in actionable mutations or tumor mutational burden.
  • Liquid biopsies showed higher detection rates for certain alterations like PTEN during progression.

An analysis presented at the European Society for Medical Oncology congress evaluated 350 patients with metastatic castration-resistant prostate cancer who experienced disease progression after undergoing androgen receptor pathway inhibitor therapy. Researchers assessed actionable genomic alterations, tumor mutational burden, and circulating tumor DNA fractions across diverse ethnic groups.

Led by Virginia Yuk-Chun Lam from King's College London, the study found no statistically significant variations in actionable mutations, tumor mutational burden, or circulating tumor DNA fractions among different ethnic demographics, although a numerical increase in BRAF mutations was observed in Black patients. The investigation also compared tissue samples with circulating tumor DNA, noting that liquid biopsies tended to yield higher fractions during disease progression.

When examining paired samples from 101 participants, the findings revealed high concordance rates for BRCA and aggressive mutations between the two testing approaches. Conversely, PTEN alterations showed lower concordance and were more frequently identified through circulating tumor DNA testing, pointing to potential complementary benefits for clinical decision-making.

What to know: The authors noted that this was a single-center study, and further multicenter cohorts with broader ethnic participation are needed to confirm these insights. Always talk to a doctor for personal medical decisions and treatment choices.

Source medpagetoday.com — medpagetoday.com/meetingcoverage/esmovideopearlsprostateca/123919 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.